胡桃醌对宫颈癌SiHa细胞增殖及细胞周期的影响

doi:10.13481/j.1671-587x.20150405

Abstract

Abstract:

Objective To explore the effects of Juglone on the proliferation and cell cycle of human cervical cancer SiHa cells, and to clarify the therapeutic effect of Juglone in cervical cancer. Methods The SiHa cells at logarithmic phase were divided into control group and different doses (10,20,40,60,80,100 μmol·L^-1) of Juglone groups.The morphological changes of the SiHa cells were observed under inverted phase contrast microscope.The proliferation activities and the inhibitory rats of growth of SiHa cells were measured by MTT assay.The cell cycle of SiHa cells was detected by flow cytometry (FMC). Results Compared with control group,the volume of SiHa cells reduced,the connection with the surrounding cells disappeared,and they detached from the surrounding cells in Juglone groups.Compared with control group,the proliferation activities of the SiHa cells in Juglone groups were decreased (P<0.05) and the inhibitory rates of growth of SiHa cells were increased in a dose-dependent manner in Juglne groups; the IC₅₀ value of Juglone was 20.7 μmol·L^-1.The results of FMC showed that the ratios of SbuG₁ state in Juglone groups were increased,and the ratios of SiHa cells at G₀/G₁ and S phases were decreased,and the ratios at G₂/M phase were increased previously then were decreased in 10 and 100 μmol·L^-1 Juglone groups compared with control group. Conclusion Juglone could inhibit the proliferation of SiHa cells and cause the increase of the SubG₁ ratio of cell cycle.

Key words: Juglone, cervical neoplasms, SiHa cells, cell cycle

CLC Number:

R285.5

ZHANG Wei, WU Yameng, CHEN Siyao, ZHANG Linna, HAN Jingchun, NA Wenting, JIN Ying. Effects of Juglone on proliferation and cell cycle of human cervical cancer SiHa cells[J].Journal of Jilin University Medicine Edition, 2015, 41(04): 697-700.

References

[1] 梁东霞.宫颈癌与HPV关系的研究进展[J].实用癌症杂志,2010,25(2):202-205.

[2] 杨森,周丽霞,陆莉,等.胡桃醌抗肿瘤机制的研究进展[J].吉林医药学院学报,2012,33(1):52-54.

[3] 孔赛,韩凤娟,张志刚.中药抗宫颈癌HPV感染的研究进展[J].世界中西医结合杂志,2014,9(3):319-322.

[4] 陈丽,张建,汪思应,等.胡桃醌对小鼠黑色素瘤细胞B16F10体内迁移的影响[J].中国临床药理学与治疗学,2012,17(9):978-982

[5] 赵行宇,杨森,周丽霞,等.胡桃醌对肝癌HepG-2细胞的增殖抑制及诱导凋亡作用[J].吉林大学学报:医学版,2013,39(2):255-258

[6] Xu H,Yu X,Qu S,et al.Juglone,isolated from Juglans mandshurica Maxim,induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells[J].Bioorg Med Chem Lett,2013,23(12):3631-3634.

[7] Xin N,Hasan M,Li W,et al.Juglans mandshurica Maxim extracts exhibit antitumor activity on HeLa cells in vitro[J].Mol Med Rep,2014,9(4):1313-1318.

[8] 张巍,赵行宇,李妍,等.不同浓度的胡桃醌对HeLa细胞的细胞凋亡作用的影响[J].解放军医学杂志,2012,38(2):13-16.

[9] Zhang W,Liu A,Li Y,et al.Anticancer activity and mechanism of Juglone on human cervical carcinoma HeLa cells[J].Can J Physiol Pharmacol,2012,90(11):1553-1558.

[10] Driver JA,Zhou XZ,Lu KP.Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease[J].Biochim Biophys Acta,2015,10.pii:S0304-4165(15)00020-3.[Epub ahead of print]

[11] Wang JZ,Liu BG,Zhang Y.Pin1-based diagnostic and therapeutic strategies for breast cancer[J].Pharmacol Res,2015,93:28-35.

[12] Chao SH,Greenleaf AL,Price DH.Juglone,an inhibitor of the peptidyl-prolyl isomerase Pin1,also directly blocks transcription[J].Nucleic Acids Res,2001,29(3):767-773.

[13] Xu HL,Yu XF,Qu SC,et al.Juglone,from Juglans mandshruica Maxim,inhibits growth and induces apoptosis in human leukemia cell HL-60 through a reactive oxygen species-dependent mechanism[J].Food Chem Toxicol,2012,50(3/4):590-596.

[14] 俞星,韩春姬,朴惠善,等.党参皂苷D 对HepG-2 细胞增殖时间效应和细胞周期的影响[J].吉林大学学报:医学版,2012,38(2):236-239.

[15] Camargo MS,Oliveira MT,Santoni MM,et al.Effects of nemorosone,isolated from the plant Clusia rosea,on the cell cycle and gene expression in MCF-7 BUS breast cancer cell lines[J].Phytomedicine,2015,22(1):153-157.

[16] 张莹,李青艳,崔泽实,等.TSG101与HIF-1α在乳腺癌组织中的表达及意义[J].中国实用内科杂志,2014,34(1):96-98.

[17] 周铮.DEK与肺癌发生发展机制的研究进展[J].中国实用内科杂志,2013,33(增1),159-163.

[18] 朱玉娴,梅长林.多囊肾病诊治进展[J].中国实用内科杂志,2014,34(3):223-226.

Effects of Juglone on proliferation and cell cycle of human cervical cancer SiHa cells

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	AN Le, YANG Jianzheng, HU Chunmei, YU Qiong, XIAO Han, HAO Shuhong, TANG Yan. Anti-apoptosis effect of polycystin-1 gene on human cervical cancer HeLa cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 776-779.
[2]	ZHOU Liuxiang, LIN Lin, HU Xinmin, WANG Xiaochun. Promotion effect of endocrine gland-derived vascular endothelial growth factor on proliferation and migration of colon cancer LoVo cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 516-520.
[3]	ZHANG Yanxia, LI Yuehui, ZHANG Lihong, ZHANG Nianping, YAN Yanyan, YANG Xiaohui, FENG Xiangling. Effects of silencing HOXA13 gene on malignant phenotypes of hepatocellular carcinoma HepG₂ and QGY-7703 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 315-320.
[4]	XU LI, ZHANG Wei. Induction of oxaziridine on apoptosis of human cervical cancer HeLa cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1161-1164.
[5]	WANG Junmei, SUN Qinyue, WU Zhe, LI Tong, LI Jing. Effects of Ginkgo Bitoba extract on differentiation and bone resorption ofosteoclasts and their mechanisms [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1130-1136.
[6]	WEN Simin, YU Duo, LYU Xin, WANG Tiejun. Influence of docetaxel combined with cisplatinand single-agent cisplatin concurrent chemoradiotherapy in prognosis of patients with advanced cervical cancer and evaluation on security [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1002-1008.
[7]	DENG Ziliang, WANG Sen, LI Peng, XIE Kuilong, LI Shuxian, ZHOU Shixiong, HE Xiaozhou, CHEN Dong, GUO Hongsheng. Enhancement of IL-37 in chemosensitivity of cervical cancer HeLa cells to cisplatin [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 862-866.
[8]	QIANG Xin, HUO Wenyan, YANG Can, FAN Yanan, SHI Caiyun, BAI Haihua. Expressions of p16INK4a protein in cervical lesion tissues of Mongolian patients and their significances [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 353-355.
[9]	LIU Qianqian, SUN Lei, BIAN Li, HAN Jinhua, JIA Xiuxiu, YAO Xiaoqing, CHEN Yubing, SONG Xinling. Relationship between cognitive differences in medical behaviors and degrees of anxiety of cervical cancer patients undergoing radiotherapy [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 115-119.
[10]	XU Lu, ZENG Linchuan, YU Yang, DOU Minghan, LU Shibing, LI Songyan, XU Ye. Role of Ca²⁺ in cisplatin-induced autophagy of cervical cancer HeLa cells [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1045-1048.
[11]	CHEN Moran, ZHAO Xingyu, LUO Jun, ZHU Wenhe, LI Yan, ZHANG Wei. Pomotion effect of juglone combined with cisplatin on apoptosis of human cervical cancer HeLa cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 901-904.
[12]	QU Meng, JIANG Rui, FENG Kai, SUN Liwei, DONG Zhiheng. Effects of gallotannin on proliferation and cell cycle of rat glomerular mesangial cells under condition of high glucose [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 920-924.
[13]	CAO Rangjuan, LI Kai, XING Wanying, WANG Yueshu, YU Wei, WU Guangzhi, CUI Shusen, LI Qiang. Expression of Disabled-1 in human breast cancer cells and its role in cell cycle [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 932-936.
[14]	ZHOU Jieping, WANG Peng, QIAN Liting, WU Aidong. Dosimetric comparison between IMRT and a single full arc,two full arc VMAT for postoperative cervical cancer patients [J]. Journal of Jilin University Medicine Edition, 2016, 42(01): 120-124.
[15]	WANG Zhiliang, YU Tenghua, QIN Qin, WU Yutong, ZHANG Wenqian, HUA Yuanyuan, XIONG Zhengai, ZHOU Wei. Influence of irreversible electroporation mediated HPV16 E6 shRNA interference plasmid in proliferation of cervical cancer SiHa cells [J]. Journal of Jilin University Medicine Edition, 2015, 41(06): 1107-1112.